2024 Annual Meeting | C136 - Pediatric Vascular Neurology
03:30 PM - 03:35 PM MDT | Introduction |
Introduction
Catherine M. Amlie-Lefond, MD, FAAN |
03:35 PM - 04:10 PM MDT | Speaker |
Cerebral Sinus Venous Thrombosis
Taryn-Leigh Surtees, MD |
04:10 PM - 04:45 PM MDT | Speaker |
Genetics of Pediatric Vascular Neurology
Patricia Musolino, MD, PhD |
04:45 PM - 05:20 PM MDT | Speaker |
Childhood Arterial Ischemic Stroke—Beyond the Stroke Code
Catherine M. Amlie-Lefond, MD, FAAN |
05:20 PM - 05:30 PM MDT | Speaker |
Questions & Answers
Catherine M. Amlie-Lefond, MD, FAAN, Taryn-Leigh Surtees, MD, Patricia Musolino, MD, PhD |
Catherine M. Amlie-Lefond, MD, FAAN | Dr. Amlie-Lefond has nothing to disclose. |
Taryn-Leigh Surtees, MD | Dr. Surtees has nothing to disclose. |
Patricia Musolino, MD, PhD | Dr. Musolino has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Minoryx Pharmaceuticals. Dr. Musolino has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Altas Venture Capital. Dr. Musolino has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for IONIS Pharmaceuticals . Dr. Musolino has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Vertex. The institution of Dr. Musolino has received research support from National Institute of Health-NINDS-R01. The institution of Dr. Musolino has received research support from Angea Biotherapeutics. The institution of Dr. Musolino has received research support from Minoryx Pharmaceuticals. Dr. Musolino has received publishing royalties from a publication relating to health care. |